Target intelligence / Profile preview

DNA damage response pathways and apoptosis regulators (DDR/Apoptosis regulators)

Target
DDR/Apoptosis regulators
Molecular classification
Enzyme, Transcription factor, Scaffold protein, Nuclease, Kinase
01

Overview

The DNA damage response (DDR) pathways and apoptosis regulators comprise a complex network of signaling cascades and proteins dedicated to maintaining genomic integrity and deciding cell fate (Jackson & Bartek, 2009, Nature). DDR pathways detect DNA lesions, signal their presence, and coordinate repair through mechanisms like base excision repair (BER), homologous recombination (HR), and non-homologous end joining (NHEJ) (Lord & Ashworth, 2012, Nature Reviews Cancer). Key sensors and transducers include ATM, ATR, and PARP, which monitor for double-strand and single-strand breaks (O'Connor, 2015, Molecular Cell). If damage is irreparable, these pathways interface with apoptosis regulators—such as the Bcl-2 family and p53—to trigger programmed cell death, preventing the propagation of oncogenic mutations (Aubrey et al., 2018, Cell Death & Differentiation). In oncology, these pathways are frequently exploited; for instance, PARP inhibitors utilize synthetic lethality in BRCA-deficient cells, while Bcl-2 inhibitors like venetoclax directly induce apoptosis in hematologic malignancies (Czabotar et al., 2014, Nature Reviews Molecular Cell Biology). Therapeutic targeting of these systems aims to overcome chemoresistance and selectively kill cancer cells with pre-existing repair defects.

Other names
DDR machineryDNA repair and cell death pathwaysGenomic integrity networkProgrammed cell death regulators
02

Mechanism of action

Inhibition of DNA repair enzymes (e.g., PARP, ATR, ATM) to induce synthetic lethality or sensitize cells to DNA-damaging agents; antagonism of anti-apoptotic proteins (e.g., Bcl-2, Mcl-1) to directly trigger programmed cell death.

03

Biological functions

DNA repairApoptosisCell cycle checkpointSignal transductionSenescence
04

Disease associations

CancerGenomic instability syndromesNeurodegenerative diseaseAging
05

Safety considerations

Myelosuppression (anemia, neutropenia, thrombocytopenia)Secondary malignancies (e.g., Myelodysplastic syndrome/Acute myeloid leukemia)Gastrointestinal toxicityTeratogenicityOff-target DNA damage in healthy proliferative tissues
06

Interacting drugs

Olaparib

9 more in the full profile.

07

Biomarkers

BRCA1 mutationBRCA2 mutationHomologous Recombination Deficiency (HRD) scorep53 statusATM lossBcl-2 expression levelsMicrosatellite Instability (MSI)

Beyond the preview

Go deeper on DNA damage response pathways and apoptosis regulators (DDR/Apoptosis regulators).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA damage response pathways and apoptosis regulators (DDR/Apoptosis regulators).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call